Navigation Links
Perrigo Reports Record Second Quarter Sales
Date:2/3/2009

On December 29, the Company announced that it received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for OTC Ibuprofen and Diphenhydramine Citrate Tablets, 200/38 mg. The Company expects to begin shipping the product to retailers during the first quarter of calendar year 2009. The product will be marketed under store brand labels and is comparable to Wyeth Consumer Healthcare's Advil(R) PM tablets, 200/38 mg, indicated as a pain reliever (NSAID)/nighttime sleep-aid. Estimated brand sales for the product for the last 12 months ending December 21, 2008 were $71 million.

Rx Pharmaceuticals

The Rx Pharmaceutical segment second quarter net sales were $40.4 million compared with $38.7 million a year ago. This increase resulted primarily from new product sales of approximately $5.7 million and a slight increase in sales volumes on the Company's existing portfolio of products. These increases were partially offset by a $1.8 million reduction in non-product revenue, along with continued pricing pressure due to changes in customer mix and increased competition in the marketplace for generic drugs. Operating income was $7.2 million, compared with $8.4 million last year.

For the first six months of fiscal year 2009, net sales for the Rx Pharmaceutical segment were relatively flat compared to fiscal 2008. Sales increased due to new product sales of approximately $10.0 million, along with an increase in sales volumes on the Company's existing portfolio of products. These increases were offset by a $6.0 million reduction in non-product revenue, along with unfavorable changes in customer mix and increased competition in the marketplace for generic drugs.

On November 19, the Company acknowledged the settlement of patent litigation brought by Sanofi-Aventis against Barr Laboratories, Inc. (Barr), a subsidiary of Barr Pharmaceuticals, In
'/>"/>

SOURCE Perrigo Company
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related medicine news :

1. Perrigo Company Announces Quarterly Dividend
2. Perrigo Company Appointed Generic Distributor by Medimetriks Pharmaceuticals
3. Perrigo Company Will Release Second Quarter Fiscal Year 2009 Results on February 3, 2009
4. Perrigo Company to Present at the 27th Annual JPMorgan Healthcare Conference
5. Perrigo Announces FDA Final Approval for Ibuprofen PM
6. Perrigo Settles Desloratadine Patent Litigation
7. Perrigo Acknowledges Settlement of NASACORT(R) AQ Nasal Spray Patent Litigation
8. Perrigo Announces FDA Tentative Approval for Ibuprofen PM
9. Perrigo Company Licenses Prescription Brands to Medimetriks Pharmaceuticals
10. Perrigo Company To Present at the Merrill Lynch Global Pharmaceutical Conference
11. Perrigo Begins Shipments of Famotidine Complete to Customers Nationwide
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2015)... ... 2015 , ... On September 30, 2015, the Career and Transfer Center (CTC) ... Maricopa Community Colleges , will be hosting a Job Expo to provide a ... opportunities. , The Expo has expanded to much more than just a typical job ...
(Date:8/29/2015)... ... August 29, 2015 , ... Targeted therapies, made possible ... lives of patients, according to a newly published report. Surviving Mesothelioma has more ... article. , The authors of the new paper focus on several types ...
(Date:8/29/2015)... ... August 29, 2015 , ... People who have heart ... emphysema), or asthma, are at higher risk from wildfire smoke especially in Calgary, ... or heart-rhythm problems (arrhythmia or irregular heartbeat) are also sensitive to air pollution. ...
(Date:8/28/2015)... ... August 28, 2015 , ... Joining a growing ... Hospital recently transitioned management companies to partner with Wound Care Advantage (WCA) to ... wound center. , Transitioning wound care management providers can be a complex ...
(Date:8/28/2015)... Mendon, IL (PRWEB) , ... August 28, 2015 , ... ... Mission” benefit concert returned for the second year to the Adams County Fairgrounds in ... event was held to raise money to support music education in the underfunded school ...
Breaking Medicine News(10 mins):Health News:Estrella Mountain Community College Expo Offers ‘One-Stop’ for Employers and Students Seeking Internships, Jobs, Careers and Service Learning Opportunities 2Health News:Top Mesothelioma Researchers Highlight Targeted Therapies in New Report, According to Surviving Mesothelioma 2Health News:Heart Fit Clinic Sounds the Alarm on Forest Fire Smoke and Chronic Heart Disease in Calgary Area 2Health News:Decatur County Memorial Hospital Transitions Wound Center Management To Wound Care Advantage and the Luvo Operating System 2Health News:Decatur County Memorial Hospital Transitions Wound Center Management To Wound Care Advantage and the Luvo Operating System 3Health News:Decatur County Memorial Hospital Transitions Wound Center Management To Wound Care Advantage and the Luvo Operating System 4Health News:Best Drug Rehabilitation Interviews Country-Rock Duo Highway Run at the 2015 "Music With A Mission" Benefit Concert 2
... of North Carolina at Chapel Hill School of Medicine ... large clinical study to evaluate the role played by ... study, which was part of the Johnston County Osteoarthritis ... who inherited a specific pattern of genetic variations in ...
... sunless tanning products, and an intervention promoting these products ... and sunburns among adult women, according to two reports ... , one of the JAMA/Archives journals. Ultraviolet radiation ... category and is the most common avoidable cause of ...
... to any length to try to become part of a ... eating something dicey, or doing illicit drugs, according to a ... "Social exclusion prompts people to use money and ... Mead (Tilburg University), Roy F. Baumeister (Florida State University), Tyler ...
... By Kathleen Doheny HealthDay Reporter , ... studies may help breast cancer patients and their ... after mastectomy. One study finds that about ... having had a mastectomy with immediate reconstruction develop ...
... HealthDay Reporter , MONDAY, Sept. 20 (HealthDay News) -- ... of hearings Monday on whether to recommend approval of ... the advisers recommend approval, it would mark the first ... America,s dinner plates and restaurant menus. Currently, genetically modified ...
... College of Law at Arizona State University has been ... Law Network, which launches today to provide legal and ... challenges such as food safety, health reform and emergency ... Program (PHLPP) received a $1.325 million grant from the ...
Cached Medicine News:Health News:UNC researchers identify genetic patterns that may predict osteoarthritis 2Health News:UNC researchers identify genetic patterns that may predict osteoarthritis 3Health News:Use of sunless tanning products common in teens, may encourage sun safety in women 2Health News:Use of sunless tanning products common in teens, may encourage sun safety in women 3Health News:Money, drugs and chicken feet? What consumers will do for social acceptance 2Health News:Breast Reconstruction After Mastectomy: Now or Later? 2Health News:Breast Reconstruction After Mastectomy: Now or Later? 3Health News:FDA Advisers Weigh Approval of Genetically Modified Salmon 2Health News:FDA Advisers Weigh Approval of Genetically Modified Salmon 3Health News:11-state regional Public Health Law Network office to be established at ASU College of Law 2Health News:11-state regional Public Health Law Network office to be established at ASU College of Law 3
(Date:8/28/2015)... Aug. 28, 2015 ... the addition of the "Investigation Report on ... offering. Originally discovered by Welfide (Mitsubishi ... Industries, Ltd) as an inflammatory drug, pranoprofen was ... Co., Ltd under the trade name of pranopulin ...
(Date:8/28/2015)... , Aug. 28, 2015 ... addition of the "Investigation Report on China,s Tobramycin ... Tobramycin is a traditional antibiotic whose eye drop and ... treatment of potential infection or inflammation caused by eye ... are able to produce tobramycin, among which ...
(Date:8/28/2015)... , Aug. 28, 2015 ... announced the addition of the "Investigation Report ... their offering. Developed by AstraZeneca plc, ... an important drug for the treatment of schizophrenia. ... quetiapine was listed in the Catalogue of Drugs ...
Breaking Medicine Technology:Investigation Report on China's Pranoprofen Market, 2010-2019 2Investigation Report on China's Tobramycin Market, 2015-2019 2China Quetiapine Market Investigation Report 2010-2019 2
... Genomics announced today that,the company entered into a ... (JHU) to commercialize products that identify,patients at risk ... a suite of,issued and pending JHU patents covering ... (IGF2). Orion,s simple blood-based risk,assessment test is being ...
... , - Data Published in the British ... Negative Impact on Overall Survival or Tumour,Progression, ... controlled,studies in 2,301 cancer patients shows that treating ... on survival, tumour,progression or deaths caused by blood ...
Cached Medicine Technology:Orion Genomics Gains Exclusive Worldwide Rights to the IGF2 Gene for Colorectal Cancer Risk Testing Through Licensing Agreement With Johns Hopkins University 2New Meta-Analysis Confirms Safety Profile for NeoRecormon in Treating Anaemia in Cancer Patients 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: